Our patient had secondary restless legs syndrome (RLS) in the left lower limb caused by end-stage renal disease (ESRD). Severe RLS symptoms persisted even after amputation of the affected limb. Considering that oral administration of a dopamine receptor agonist was effective in treating the RLS in the phantom limb in this case, dysfunction of the central dopaminergic system was thought to be involved in the phantom limb-RLS mechanism. The persistence of RLS symptoms even after amputation of the affected limb suggests that the area responsible for ESRD-related RLS symptoms exists at the spinal level or in the higher central nervous system.
Introduction
Restless legs syndrome (RLS) is characterized by uncomfortable sensations occurring primarily at night and mostly deep within a lower limb with an irresistible urge to move the affected limb. Clinical diagnostic criteria for RLS have been established by the International Restless Legs Syndrome Study Group (IRLSSG) (1) , with positive indications for the following four criteria being necessary for a diagnosis: 1) an urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs; 2) the urge to move or the development or worsening of unpleasant sensations during periods of rest or inactivity such as lying or sitting; 3) the urge to move or unpleasant sensations that are partially or totally relieved by movement such as walking or stretching, at least as long as the activity continues; 4) the urge to move or unpleasant sensations that worsen in the evening or during the night or only occur in the evening or at night.
Results of various studies have revealed the prevalence of RLS in the general population to be 7.2-9.6% in Europe and America (2, 3) and 1.8-4.0% in Japan (4, 5) . The prevalence of RLS is also known to be higher among women than men in all races (3) (4) (5) . RLS is categorized into idiopathic cases and secondary cases according to the somatic conditions responsible for such conditions as end-stage renal disease (ESRD), pregnancy and iron deficiency. The prevalence of ESRD-related RLS has been reported to be approximately 20% (6) (7) (8) , which is much higher than the rate observed among the general population. Nevertheless, the pathophysiology of ESRD-related RLS remains unclear.
We cared for a woman with secondary RLS in the left lower limb caused by ESRD most likely due to diabetic nephropathy. In this patient, severe RLS symptoms persisted even after amputation of the affected limb. The oral administration of 0.8 mg/day of talipexole, an ergot dopamine receptor agonist, markedly improved the RLS symptoms in the phantom limb. Based on the patient's clinical course and treatment response to this compound, we examined the relationship between the pathophysiology of ESRD-related RLS and phantom limbs. hospital to receive insulin injections beginning at 47 years of age after a 22-year disease history of type 2 diabetes mellitus. She developed diabetic nephropathy and began to undergo hemodialysis four hours twice a week due to ESRD at 55 years of age. Shortly after starting hemodialysis, uncomfortable sensations with an irresistible urge to move appeared primarily at night, especially throughout the left lower limb. To relieve the uncomfortable sensations, the patient consulted a neurologist at 58 years of age. Subsequently, she received a diagnosis of RLS. After the frequency of the hemodialysis sessions was increased to three times per week (with each session lasting four hours), the RLS symptoms disappeared almost completely. However, they recurred two years later and began to appear almost every day within a few months. At 61 years of age, the patient began to report severe pain caused by diabetic gangrene in her bilateral heels as a comorbidity of diabetes. One year later, she underwent left lower limb amputation above the knee due to severe arteriosclerosis obliterans (ASO). However, the RLS symptoms persisted in the area of the left lower limb that had been lost to amputation. The RLS symptoms appeared only in the left lower limb. Due to the RLS symptoms in the phantom limb and the pain associated with gangrene in the right calcaneal region, the patient suffered from severe insomnia. With treatment administered by an attending neurologist, the pain was relieved sufficiently. However, the RLS symptoms in the phantom limb persisted for a long period with no changes.
At 64 years of age, the patient consulted our outpatient clinic seeking improvement of the RLS symptoms in the phantom limb and associated insomnia. At that time, the International Restless Legs Syndrome Study Group Rating Scale (IRLS) (9) score was 34 points, indicating extremely severe RLS symptoms. During a clinical interview, the patient stated that the uncomfortable RLS sensations were almost identical to those experienced before amputation and that the symptoms appeared only in the left amputated limb starting around 4 pm and continuing until midnight every day. When the RLS sensations became particularly strong, she repeatedly felt an irresistible urge to move in her wheelchair (because she could not walk by herself) or shake her body. The uncomfortable sensations were markedly alleviated by movement of the trunk and hip but worsened at rest. She had no family history of RLS.
Shortly after the first visit, she underwent nocturnal polysomnography (PSG), with results showing that the periodic limb movements during sleep (PLMS) index was 72.7/h, whereas the awake (PLMW) index was 17.8/h in the right lower limb. As inferred from the hypnogram (Figure) , a diffuse appearance of PLMS was observed throughout the nocturnal sleep period, except in the rapid eye movement (REM) stage.
Laboratory findings showed severe renal dysfunction (urea nitrogen: 76 mg/dL, normal value: 8.0-22.0 mg/dL; creatinine: 5.26 mg/dL, normal value: 0.61-1.04 mg/dL) and iron deficiency (serum iron: 28 μg/dL, normal value: 48-154 μg/dL; ferritin: 13.4 ng/mL, normal value: 3.6-114.0 ng/ mL). A nerve conduction study was performed in the right upper limb only due to the presence of a dialysis shunt in the left upper limb and gangrene in the lower extremities. For the nerve conduction study, the room temperature was maintained above 25°C. A motor nerve conduction study showed that the distal motor latency was prolonged in the median nerve (5.1 ms, normal <4.1) but remained normal in the ulnar nerve (3.8 ms, normal <4.0). The distally evoked compound muscle action potentials had a low amplitude (1.4 mV, normal >4.7), and the motor conduction velocity was reduced (37 m/s, normal >47) in the median nerve. The ulnar compound muscle action potentials also had a low amplitude (3.2 mV, normal >4.1) along with conduction slowing (34 m/s, normal >51). An antidromic sensory nerve conduction study demonstrated reduced sensory conduction velocities in the median (28 m/s, normal >46) and ulnar (30 m/s, normal >48) nerves. The sensory nerve action potentials had a low amplitude in the median nerve (4.4 μV, normal >18) with a normal amplitude in the ulnar nerve (18 μV, normal >13). The nerve conduction study results suggested the existence of a polyneuropathy such as diabetic neuropathy.
After receiving a definitive diagnosis of RLS, the patient began treatment with 0.8 mg/day of talipexole at night. Shortly thereafter, her RLS symptoms markedly improved. Three months after treatment, the IRLS score decreased to 12 points. Since then, her attending dialysis physician has regularly prescribed the same dose of talipexole. The patient has not suffered from insomnia for over a year, although mild RLS symptoms continue to be present two to three days per week.
Discussion
Our case is the fifth case of RLS occurring in a phantom limb reported in the relevant literature in English (10) (11) (12) (13) . Previously reported case details are presented in Table. With respect to the point that the RLS symptoms appeared in phantom limbs, all reported cases exhibited a common feature. However, the RLS symptoms had already existed prior to amputation and persisted even after amputation in this case. Regarding this point, this case differed from the other previously reported cases.
In our case, the PLM index was extremely high during both sleep and wakefulness, corresponding to the characteristics of RLS secondary to ESRD, which more frequently accompany PLMS than idiopathic RLS (14) . Secondary RLS in ESRD patients is reported to improve following renal transplantation (15) or a change in dialysis schedule to short daily dialysis sessions (16). The results described in these reports imply that accumulation of uremic substances is the primary cause of RLS in this population. Regarding the mechanisms underlying the development of uremic RLS, some researchers have assigned importance to neuropathy attributable to accumulated uremic substances. However, judging from the fact that our patient exhibited RLS symptoms even after amputation, involvement of peripheral nervous dysfunction in the mechanism of RLS is negligible. The area responsible for RLS exists at the spinal level or in the higher central nervous system where uremic substances can accumulate. In addition, considering that a dopaminergic agonist was effective in treating the RLS in this case, as in other cases of RLS in phantom limbs (10) (11) (12) (13) 17) , dysfunction of the central dopaminergic system is thought to be involved in the mechanisms underlying ESRD-related phantom limb-RLS.
A study using 3D-MRI voxel-based morphometry revealed significantly decreased gray matter volume of the bihemispheric primary somatosensory cortex and left-sided primary motor areas in RLS patients. The amount of decrease in the volume of this area was found to be significantly correlated with both the severity of RLS symptoms and disease duration (18) . Moreover, a study using regional fractional anisotropy (FA) on diffusion tensor imaging (DTI) as a quantitative marker of white matter integrity of the brain revealed significantly decreased FA bihemispherically in close proximity to the primary and associate motor and somatosensory cortices in patients with RLS (19) . Reportedly, reorganization of the motor and somatosensory cortices plays an important role, especially in relation to the mechanisms underlying phantom limb pain (20) . Considering the possible involvement of the primary motor and primary somatosensory cortices in the mechanisms of RLS shown in the MRI study described above, the areas responsible for RLS and phantom limb pain might overlap in these areas.
Dempewolf et al. (13) reported similar phenomena. Giummarra et al. (21) pointed out similarities in sensory symptoms (sensations such as jitteriness, burning sensations, throbbing, searing, tugging, pulling, aching, itching and formication) between nocturnal phantom limb pain and RLS based on results of a questionnaire survey administered to 283 amputees. In light of these similarities, a differential diagnosis must be made between RLS symptoms and other sensations of discomfort in amputated limbs. For cases in which a differential diagnosis cannot be made easily, the existence of PLMS and a favorable response to a dopaminergic drug, as was true in our case, can support a diagnosis of RLS (1).
In conclusion, RLS symptoms occurring secondary to ESRD in a phantom limb might persist even after amputation of the affected limb, thus suggesting that the area responsible for the disorder exists at the spinal level or in the higher central nervous system. Considering that a dopaminergic agonist was effective in treating the RLS in this case, central dopaminergic system dysfunction is thought to be involved in the mechanisms underlying RLS in phantom limbs developing secondary to ESRD.
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